Skip to content

Drug interactions

Octreotide + Ranolazine

Severity: Moderate

Octreotide and Ranolazine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, and octreotide can also cause bradycardia and electrolyte disturbance. Combined use may increase the risk of ventricular arrhythmia, particularly in patients with other risk factors.

What this interaction means in plain words

Octreotide and Ranolazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Octreotide belongs to Endocrine; Ranolazine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Additive prolongation of cardiac repolarization (QTc) through pharmacodynamic effects.

What to do

Obtain a baseline ECG and monitor QTc after starting the combination. Correct potassium and magnesium abnormalities and avoid adding further QT-prolonging drugs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Octreotide and Ranolazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Octreotide with Ranolazine?

MediHelp rates the interaction as moderate. Octreotide and Ranolazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QT interval, and octreotide can also cause bradycardia and electrolyte disturbance. Combined use may increase the risk of ventricular arrhythmia, particularly in patients with other risk factors.

How serious is the interaction between Octreotide and Ranolazine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor QTc after starting the combination. Correct potassium and magnesium abnormalities and avoid adding further QT-prolonging drugs.

What other medicines interact with Ranolazine?

MediHelp also lists interactions of Ranolazine with, for example, Adagrasib, Amobarbital, Apalutamide. The full list is on the Ranolazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in